4.6 Article

Mdm2 widens its repertoire

Journal

CELL CYCLE
Volume 6, Issue 7, Pages 827-829

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/cc.6.7.4086

Keywords

ubiquitination; Mdm2; p53; DNA damage; co-factor JMY

Categories

Funding

  1. Medical Research Council [G0500905] Funding Source: Medline
  2. MRC [G0500905] Funding Source: UKRI
  3. Medical Research Council [G0500905] Funding Source: researchfish

Ask authors/readers for more resources

The p53 tumor suppressor protein is a DNA damage responsive transcription factor that affects diverse cellular processes which include transcription, DNA synthesis and repair, cell cycle arrest, senescence and apoptosis. The Mdm2 oncoprotein is a primary regulator of p53, mediating p53 control via ubiquitin-dependent proteasomal degradation. During DNA damage, the interaction between p53 and Mdm2 is reduced, which allows p53 levels to accumulate. p53 activity is tightly controlled and regulated at a multiplicity of levels, and the importance of co-factors that influence p53 activity is becoming increasingly evident. Recent studies have highlighted the role of Mdm2 in the control of p53 co-factors. Thus, Mdm2 targets JMY, a p53 co-factor, for ubiquitin-dependent proteasomal degradation and in doing so overcomes the ability of JMY to augment the p53 response. These results define a new functional relationship between control of p53 activity and Mdm2, and suggest that transcription co-factors which facilitate the p53 response are important targets through which Mdm2 mediates its oncogenic activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available